Document Detail

Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
MedLine Citation:
PMID:  21329899     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The aim of this study was to compare the reproducibility of 7 late gadolinium enhancement (LGE) quantification techniques across 3 conditions in which LGE is known to be important: acute myocardial infarction (AMI), chronic myocardial infarction (CMI), and hypertrophic cardiomyopathy (HCM).
BACKGROUND: LGE by cardiac magnetic resonance is the gold-standard technique for assessing myocardial scar. No consensus exists on the best method for its quantification, and research in this area is scant. Techniques include manual quantification, thresholding by 2, 3, 4, 5, or 6 SDs above remote myocardium, and the full width at half maximum (FWHM) technique. To date, LGE has been linked to outcome in 3 conditions: AMI, CMI, and HCM.
METHODS: Sixty patients with 3 LGE etiologies (AMI, n = 20; CMI, n = 20; HCM, n = 20) were scanned for LGE. LGE volume was quantified using the 7 techniques. Mean LGE volume, interobserver and intraobserver reproducibility, and impact on sample size were assessed.
RESULTS: LGE volume varied significantly with the quantification method used. There was no statistically significant difference between LGE volume by the FWHM, manual, and 6-SD or 5-SD techniques. The 2-SD technique generated LGE volumes up to 2 times higher than the FWHM, 6-SD, and manual techniques. The reproducibility of all techniques was worse in HCM than AMI or CMI. The FWHM technique was the most reproducible in all 3 conditions compared with any other method (p < 0.001). Use of the FWHM technique for LGE quantification in paired analysis would lead to at least a 60% reduction in required sample size compared with any other method.
CONCLUSIONS: Regardless of the disease under study, the FWHM technique for LGE quantification gives LGE volume mean results similar to manual quantification and is statistically the most reproducible, reducing required sample sizes by up to one-half.
Andrew S Flett; Jonathan Hasleton; Christopher Cook; Derek Hausenloy; Giovanni Quarta; Cono Ariti; Vivek Muthurangu; James C Moon
Related Documents :
23714269 - Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventric...
23979499 - Super bowl outcome's association with cardiovascular death.
21256469 - Risk of death and myocardial infarction in patients with peripheral arterial disease un...
21193539 - Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of progr...
15607999 - Prognostic significance of admission levels of troponin i in patients with acute ischae...
9192239 - Postoperative influences of surgical cryoablation for wolff-parkinson-white syndrome--a...
18931029 - Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involveme...
20657679 - Ventricular asystole due to inhibition of ventricular backup pacing by a dual chamber p...
8780929 - The myocardial fibrosis in patients with dilated cardiomyopathy. the application of ima...
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JACC. Cardiovascular imaging     Volume:  4     ISSN:  1876-7591     ISO Abbreviation:  JACC Cardiovasc Imaging     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-18     Completed Date:  2011-06-13     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  101467978     Medline TA:  JACC Cardiovasc Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  150-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiomyopathy, Hypertrophic / complications,  diagnosis*,  pathology
Cicatrix / diagnosis*,  etiology,  pathology
Contrast Media / diagnostic use
Image Interpretation, Computer-Assisted
Magnetic Resonance Imaging*
Meglumine / diagnostic use
Middle Aged
Myocardial Infarction / complications,  diagnosis*,  pathology
Myocardium / pathology*
Observer Variation
Organometallic Compounds / diagnostic use
Predictive Value of Tests
Reproducibility of Results
Retrospective Studies
Grant Support
FS/08/012/24454//British Heart Foundation; FS/08/028/24767//British Heart Foundation; FS/10/72/28568//British Heart Foundation
Reg. No./Substance:
0/Contrast Media; 0/Organometallic Compounds; 0/gadoterate meglumine; 6HG8UB2MUY/Meglumine
Comment In:
JACC Cardiovasc Imaging. 2011 Nov;4(11):1223; author reply 1224   [PMID:  22093276 ]
JACC Cardiovasc Imaging. 2011 Feb;4(2):157-60   [PMID:  21329900 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Noninvasive evaluation of coronary reperfusion by CT angiography in patients with STEMI.
Next Document:  Long-Term Prognostic Value of Dobutamine Stress CMR.